202 related articles for article (PubMed ID: 34208360)
21. Porphyromonas gingivalis attenuates the insulin-induced phosphorylation and translocation of forkhead box protein O1 in human hepatocytes.
Takamura H; Yoshida K; Okamura H; Fujiwara N; Ozaki K
Arch Oral Biol; 2016 Sep; 69():19-24. PubMed ID: 27214121
[TBL] [Abstract][Full Text] [Related]
22. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
23. FOXO1 is downregulated in obese mice subjected to short-term strength training.
Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
[TBL] [Abstract][Full Text] [Related]
24. TGF-β1 Signaling Impairs Metformin Action on Glycemic Control.
Pan Q; Ai W; Guo S
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397103
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
26. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
27. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
[TBL] [Abstract][Full Text] [Related]
28. PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway.
Chen L; Sun X; Xiao H; Xu F; Yang Y; Lin Z; Chen Z; Quan S; Huang H
Exp Cell Res; 2019 Aug; 381(2):301-310. PubMed ID: 31095939
[TBL] [Abstract][Full Text] [Related]
29. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
30. Red Pepper (
Kim HK; Jeong J; Kang EY; Go GW
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32842462
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction.
Liu Q; Zhang FG; Zhang WS; Pan A; Yang YL; Liu JF; Li P; Liu BL; Qi LW
Theranostics; 2017; 7(16):4001-4012. PubMed ID: 29109794
[No Abstract] [Full Text] [Related]
33. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
[TBL] [Abstract][Full Text] [Related]
34. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
Yadav H; Devalaraja S; Chung ST; Rane SG
J Biol Chem; 2017 Feb; 292(8):3420-3432. PubMed ID: 28069811
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
36. Hepatic GSK3β-Dependent CRY1 Degradation Contributes to Diabetic Hyperglycemia.
Kim YY; Jang H; Lee G; Jeon YG; Sohn JH; Han JS; Lee WT; Park J; Huh JY; Nahmgoong H; Han SM; Kim J; Pak M; Kim S; Kim JS; Kim JB
Diabetes; 2022 Jul; 71(7):1373-1387. PubMed ID: 35476750
[TBL] [Abstract][Full Text] [Related]
37. Dendrobium officinale polysaccharide ameliorates diabetic hepatic glucose metabolism via glucagon-mediated signaling pathways and modifying liver-glycogen structure.
Liu Y; Yang L; Zhang Y; Liu X; Wu Z; Gilbert RG; Deng B; Wang K
J Ethnopharmacol; 2020 Feb; 248():112308. PubMed ID: 31622745
[TBL] [Abstract][Full Text] [Related]
38. FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice.
Lee YK; Diaz B; Deroose M; Lee SX; Belvedere S; Accili D; Leibel RL; Lin HV
Mol Metab; 2021 Jul; 49():101187. PubMed ID: 33577983
[TBL] [Abstract][Full Text] [Related]
39. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
40. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
